$MRK News
Health-care sector taking a broad beating as pricing fears grow 2:39 p.m. Dec. 23, 2014 - Tomi Kilgore
FDA approves Bristol-Myers’s skin cancer treatment Opdivo 6:09 p.m. Dec. 22, 2014 - Ron Winslow
Nike slips after hours as orders fail to impress 6:38 p.m. Dec. 18, 2014 - MarketWatch
Merck acquires OncoEthix for up to $375 million 8:41 a.m. Dec. 18, 2014 - Angela Chen
From China to the U.S., a surreal week in business news 9:28 a.m. Dec. 12, 2014 - Marek Fuchs
Human trial of experimental Merck Ebola vaccine is suspended 2:17 p.m. Dec. 11, 2014 - Jeanne Whalen
Restoration Hardware shares jump on earnings beat 6:46 p.m. Dec. 10, 2014 - MarketWatch
Merck drug shrank tumors in some breast cancer patients in trial 8:57 a.m. Dec. 10, 2014 - Peter Loftus
Here are today’s biggest S&P 500 losers ... and five winners 12:51 p.m. Dec. 9, 2014 - Philip van Doorn
H&R Block shares fall on quarterly miss 6:41 p.m. Dec. 8, 2014 - Sue Chang
The S&P 500 recorded its biggest drop in nearly 7 weeks 4:33 p.m. Dec. 8, 2014 - Sara Sjolin
Russell 2000 rattles cage on major resistance 11:15 a.m. Dec. 8, 2014 - Michael Ashbaugh
Dow 18,000 beckons, but a bottom in oil prices does not 7:42 a.m. Dec. 8, 2014 - Shawn Langlois
Newscast: Oil prices plunge 7:38 a.m. Dec. 8, 2014 - MarketWatch
Merck to buy Cubist Pharmaceuticals for $8.4 billion 7:26 a.m. Dec. 8, 2014 - Peter Loftus
Merck to buy Cubist Pharmaceuticals in $9.5 billion deal 7:13 a.m. Dec. 8, 2014 - Tomi Kilgore
Merck & Co. to buy Cubist Pharma in total deal valued at $9.5 billion 7:05 a.m. Dec. 8, 2014 - Carla Mozee
Merck's per-share bid for Cubist's stock is 37% above Friday's closing price 7:03 a.m. Dec. 8, 2014 - Tomi Kilgore
Merck & Co.: Cubist Pharma purchase is a 35% premium to shareholders 7:03 a.m. Dec. 8, 2014 - Carla Mozee
Merck to pay $102 a share for Cubist 7:02 a.m. Dec. 8, 2014 - Tomi Kilgore
9 Hot Healthcare Dividend Dogs Dog 12% To 46% December Upsides 2:11 a.m. Today - Seeking Alpha
Today’s Top 5 Stock Picks: Innovative Global Values 11:44 a.m. Jan. 2, 2015 - Barrons.com
45 Blue-Chip Dividend Stocks That Increased Payouts in Q4 2014 8:32 a.m. Jan. 2, 2015 - InvestorPlace.com
3 Best American Funds for 2015 12:30 a.m. Jan. 2, 2015 - InvestorPlace.com
Despite Positive Phase 3 Results, Radius Health May Warrant A Short Sale 5:00 a.m. Dec. 31, 2014 - Seeking Alpha
Gilead Long-Term Prognosis Is Promising 2:10 p.m. Dec. 30, 2014 - Seeking Alpha
Esperion Therapeutics: ETC-1002 Is Appealing, But The Valuation Is Not 7:22 a.m. Dec. 30, 2014 - Seeking Alpha
DoctoRx Positions For 2015: I Have Cut Back On My Exposure To All Biotech Substantially 7:05 a.m. Dec. 30, 2014 - Seeking Alpha
Health Care SPDR Consolidating Gains as J&J, Merck Show Negative Trends 6:10 a.m. Dec. 30, 2014 - TheStreet.com
Why Dogs Of The Dow Doesn't Work Anymore 4:46 a.m. Dec. 30, 2014 - Seeking Alpha
Tetraphase Hits 52-Week High on Positive Antibiotic Data - Analyst Blog 12:10 p.m. Dec. 29, 2014 - Zacks.com
NewLink and Merck Get a $30M Contract for Ebola Candidate - Analyst Blog 12:00 p.m. Dec. 29, 2014 - Zacks.com
5 Top Pharmaceutical Stock Picks for 2015 9:35 a.m. Dec. 29, 2014 - 247WallSt.com
Should You Buy the Dogs of the Dow in 2015? 6:20 a.m. Dec. 29, 2014 - InvestorPlace.com
The Real Source Of A Santa Claus Rally 8:35 p.m. Dec. 26, 2014 - Seeking Alpha
Viral Investing: Ebola Drug Makers' Varied Strategies 3:09 p.m. Dec. 26, 2014 - Investors Business Daily
4 Potential Blockbuster Drugs The FDA Just Approved 11:35 a.m. Dec. 26, 2014 - Investors Business Daily
Merck's Diabetes Pipeline Candidates Are Sure Bets; Only A Matter Of When 10:58 a.m. Dec. 26, 2014 - Seeking Alpha
Can You Retire In Your 50s? 2:38 a.m. Dec. 26, 2014 - Seeking Alpha
Bristol-Myers Oncology Drug Opdivo Receives FDA Approval - Analyst Blog 5:45 p.m. Dec. 23, 2014 - Zacks.com
EnWave Signs Non-Exclusive License With Merck, Agrees to Build Second Generation Radiant Energy Vacuum Dryer 9:01 a.m. Dec. 29, 2014 - Marketwired
Pharmaceuticals, Medicines, Supplements and Drug Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 325400 8:15 a.m. Dec. 23, 2014 - PR Newswire - PRF
Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market (Tedizolid Phosphate, Ceftolozane/Tazobactam, Ceftazidime/Avibactam, Amikacin Inhale, Plazomicin, and Synflorix) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 202 7:08 a.m. Dec. 23, 2014 - PR Newswire - PRF
Harris & Harris Group Notes Publicly Traded Portfolio Company Enumeral Biomedical's Collaboration With Merck 12:29 p.m. Dec. 22, 2014 - GlobeNewswire
NewLink Genetics, Merck Collaboration to Manufacture Ebola Vaccine Candidate Supported by $30 Million Government Award 8:01 a.m. Dec. 22, 2014 - GlobeNewswire
Alnylam Announces Planned Departure of Chief Business Officer, Laurence Reid, Ph.D. 8:00 a.m. Dec. 19, 2014 - BusinessWire - BZX
Merck Begins Tender Offer to Acquire Cubist 8:00 a.m. Dec. 19, 2014 - BusinessWire - BZX
Electrochromic Glass Market Will Reach $ 2.2 billion by 2020 says New NanoMarkets Report 11:14 a.m. Dec. 18, 2014 - PR Newswire - PRF
New Energy a Little More Insulated to Sharp Drop in Oil than Before 9:53 a.m. Dec. 18, 2014 - ACCESSWIRE
Enumeral and Merck Form Collaboration for Predicting Clinical Drug Response with Human-driven Immune Profiling Platform 8:02 a.m. Dec. 18, 2014 - BusinessWire - BZX
Merck Acquires OncoEthix, a Privately Held Oncology Company Developing Novel BET Inhibitors for Hematological and Solid Cancers 7:30 a.m. Dec. 18, 2014 - BusinessWire - BZX
Hemispherx's Ampligen(R) Provides Anti-Tumor Activity Analogous to Emerging Immune Checkpoint Inhibitors 8:31 a.m. Dec. 16, 2014 - GlobeNewswire
SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Cubist Pharmaceuticals, Inc. Regarding the Fairness of the Sale of the Company 7:07 p.m. Dec. 15, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: Brower Piven Launches An Investigation Into The Proposed Sale Of Cubist Pharmaceuticals, Inc. And Encourages Investors To Contact The Firm For Additional Information 5:07 p.m. Dec. 12, 2014 - BusinessWire - BZX
CBST SHAREHOLDER ALERT: The Law Offices of Vincent Wong Launches Investigation of the Board of Directors of Cubist Pharmaceuticals, Inc.in Connection With the Fairness of the Sale of the Companyto Merck & Co. 10:19 a.m. Dec. 12, 2014 - BusinessWire - BZX
Technical Data on Pharma Stocks - Pfizer, Merck, AbbVie, Akorn, and The Medicines 9:10 a.m. Dec. 12, 2014 - PR Newswire - PRF
CBST SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation of the Board of Directors of Cubist Pharmaceuticals, Inc. Regarding the Fairness of the Sale of the Company to Merck & Co. 12:51 p.m. Dec. 10, 2014 - BusinessWire - BZX
Merck Announces Appointment of Dr. Julie Gerberding as Executive Vice President for Strategic Communications, Global Public Policy and Population Health 9:30 a.m. Dec. 10, 2014 - BusinessWire - BZX
International Breast Cancer Study Group, Breast International Group and Merck Announce Opening of International PANACEA Study of Patients with HER2+ Breast Cancer 8:45 a.m. Dec. 10, 2014 - BusinessWire - BZX
Data Investigating KEYTRUDA® (pembrolizumab), Merck’s Anti-PD-1 Therapy, in Patients with Advanced Triple-Negative Breast Cancer Presented at 2014 San Antonio Breast Cancer Symposium 8:30 a.m. Dec. 10, 2014 - BusinessWire - BZX
Health-care sector taking a broad beating as pricing fears grow 2:39 p.m. Dec. 23, 2014 - Tomi Kilgore
FDA approves Bristol-Myers’s skin cancer treatment Opdivo 6:09 p.m. Dec. 22, 2014 - Ron Winslow
Nike slips after hours as orders fail to impress 6:38 p.m. Dec. 18, 2014 - MarketWatch
Merck acquires OncoEthix for up to $375 million 8:41 a.m. Dec. 18, 2014 - Angela Chen
From China to the U.S., a surreal week in business news 9:28 a.m. Dec. 12, 2014 - Marek Fuchs
Human trial of experimental Merck Ebola vaccine is suspended 2:17 p.m. Dec. 11, 2014 - Jeanne Whalen
Restoration Hardware shares jump on earnings beat 6:46 p.m. Dec. 10, 2014 - MarketWatch
Merck drug shrank tumors in some breast cancer patients in trial 8:57 a.m. Dec. 10, 2014 - Peter Loftus
Here are today’s biggest S&P 500 losers ... and five winners 12:51 p.m. Dec. 9, 2014 - Philip van Doorn
H&R Block shares fall on quarterly miss 6:41 p.m. Dec. 8, 2014 - Sue Chang
The S&P 500 recorded its biggest drop in nearly 7 weeks 4:33 p.m. Dec. 8, 2014 - Sara Sjolin
Russell 2000 rattles cage on major resistance 11:15 a.m. Dec. 8, 2014 - Michael Ashbaugh
Dow 18,000 beckons, but a bottom in oil prices does not 7:42 a.m. Dec. 8, 2014 - Shawn Langlois
Newscast: Oil prices plunge 7:38 a.m. Dec. 8, 2014 - MarketWatch
Merck to buy Cubist Pharmaceuticals for $8.4 billion 7:26 a.m. Dec. 8, 2014 - Peter Loftus
Merck to buy Cubist Pharmaceuticals in $9.5 billion deal 7:13 a.m. Dec. 8, 2014 - Tomi Kilgore
Merck & Co. to buy Cubist Pharma in total deal valued at $9.5 billion 7:05 a.m. Dec. 8, 2014 - Carla Mozee
Merck's per-share bid for Cubist's stock is 37% above Friday's closing price 7:03 a.m. Dec. 8, 2014 - Tomi Kilgore
Merck & Co.: Cubist Pharma purchase is a 35% premium to shareholders 7:03 a.m. Dec. 8, 2014 - Carla Mozee
Merck to pay $102 a share for Cubist 7:02 a.m. Dec. 8, 2014 - Tomi Kilgore
9 Hot Healthcare Dividend Dogs Dog 12% To 46% December Upsides 2:11 a.m. Today - Seeking Alpha
Today’s Top 5 Stock Picks: Innovative Global Values 11:44 a.m. Jan. 2, 2015 - Barrons.com
45 Blue-Chip Dividend Stocks That Increased Payouts in Q4 2014 8:32 a.m. Jan. 2, 2015 - InvestorPlace.com
3 Best American Funds for 2015 12:30 a.m. Jan. 2, 2015 - InvestorPlace.com
Despite Positive Phase 3 Results, Radius Health May Warrant A Short Sale 5:00 a.m. Dec. 31, 2014 - Seeking Alpha
Gilead Long-Term Prognosis Is Promising 2:10 p.m. Dec. 30, 2014 - Seeking Alpha
Esperion Therapeutics: ETC-1002 Is Appealing, But The Valuation Is Not 7:22 a.m. Dec. 30, 2014 - Seeking Alpha
DoctoRx Positions For 2015: I Have Cut Back On My Exposure To All Biotech Substantially 7:05 a.m. Dec. 30, 2014 - Seeking Alpha
Health Care SPDR Consolidating Gains as J&J, Merck Show Negative Trends 6:10 a.m. Dec. 30, 2014 - TheStreet.com
Why Dogs Of The Dow Doesn't Work Anymore 4:46 a.m. Dec. 30, 2014 - Seeking Alpha
Tetraphase Hits 52-Week High on Positive Antibiotic Data - Analyst Blog 12:10 p.m. Dec. 29, 2014 - Zacks.com
NewLink and Merck Get a $30M Contract for Ebola Candidate - Analyst Blog 12:00 p.m. Dec. 29, 2014 - Zacks.com
5 Top Pharmaceutical Stock Picks for 2015 9:35 a.m. Dec. 29, 2014 - 247WallSt.com
Should You Buy the Dogs of the Dow in 2015? 6:20 a.m. Dec. 29, 2014 - InvestorPlace.com
The Real Source Of A Santa Claus Rally 8:35 p.m. Dec. 26, 2014 - Seeking Alpha
Viral Investing: Ebola Drug Makers' Varied Strategies 3:09 p.m. Dec. 26, 2014 - Investors Business Daily
4 Potential Blockbuster Drugs The FDA Just Approved 11:35 a.m. Dec. 26, 2014 - Investors Business Daily
Merck's Diabetes Pipeline Candidates Are Sure Bets; Only A Matter Of When 10:58 a.m. Dec. 26, 2014 - Seeking Alpha
Can You Retire In Your 50s? 2:38 a.m. Dec. 26, 2014 - Seeking Alpha
Bristol-Myers Oncology Drug Opdivo Receives FDA Approval - Analyst Blog 5:45 p.m. Dec. 23, 2014 - Zacks.com
EnWave Signs Non-Exclusive License With Merck, Agrees to Build Second Generation Radiant Energy Vacuum Dryer 9:01 a.m. Dec. 29, 2014 - Marketwired
Pharmaceuticals, Medicines, Supplements and Drug Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 325400 8:15 a.m. Dec. 23, 2014 - PR Newswire - PRF
Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market (Tedizolid Phosphate, Ceftolozane/Tazobactam, Ceftazidime/Avibactam, Amikacin Inhale, Plazomicin, and Synflorix) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 202 7:08 a.m. Dec. 23, 2014 - PR Newswire - PRF
Harris & Harris Group Notes Publicly Traded Portfolio Company Enumeral Biomedical's Collaboration With Merck 12:29 p.m. Dec. 22, 2014 - GlobeNewswire
NewLink Genetics, Merck Collaboration to Manufacture Ebola Vaccine Candidate Supported by $30 Million Government Award 8:01 a.m. Dec. 22, 2014 - GlobeNewswire
Alnylam Announces Planned Departure of Chief Business Officer, Laurence Reid, Ph.D. 8:00 a.m. Dec. 19, 2014 - BusinessWire - BZX
Merck Begins Tender Offer to Acquire Cubist 8:00 a.m. Dec. 19, 2014 - BusinessWire - BZX
Electrochromic Glass Market Will Reach $ 2.2 billion by 2020 says New NanoMarkets Report 11:14 a.m. Dec. 18, 2014 - PR Newswire - PRF
New Energy a Little More Insulated to Sharp Drop in Oil than Before 9:53 a.m. Dec. 18, 2014 - ACCESSWIRE
Enumeral and Merck Form Collaboration for Predicting Clinical Drug Response with Human-driven Immune Profiling Platform 8:02 a.m. Dec. 18, 2014 - BusinessWire - BZX
Merck Acquires OncoEthix, a Privately Held Oncology Company Developing Novel BET Inhibitors for Hematological and Solid Cancers 7:30 a.m. Dec. 18, 2014 - BusinessWire - BZX
Hemispherx's Ampligen(R) Provides Anti-Tumor Activity Analogous to Emerging Immune Checkpoint Inhibitors 8:31 a.m. Dec. 16, 2014 - GlobeNewswire
SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Cubist Pharmaceuticals, Inc. Regarding the Fairness of the Sale of the Company 7:07 p.m. Dec. 15, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: Brower Piven Launches An Investigation Into The Proposed Sale Of Cubist Pharmaceuticals, Inc. And Encourages Investors To Contact The Firm For Additional Information 5:07 p.m. Dec. 12, 2014 - BusinessWire - BZX
CBST SHAREHOLDER ALERT: The Law Offices of Vincent Wong Launches Investigation of the Board of Directors of Cubist Pharmaceuticals, Inc.in Connection With the Fairness of the Sale of the Companyto Merck & Co. 10:19 a.m. Dec. 12, 2014 - BusinessWire - BZX
Technical Data on Pharma Stocks - Pfizer, Merck, AbbVie, Akorn, and The Medicines 9:10 a.m. Dec. 12, 2014 - PR Newswire - PRF
CBST SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation of the Board of Directors of Cubist Pharmaceuticals, Inc. Regarding the Fairness of the Sale of the Company to Merck & Co. 12:51 p.m. Dec. 10, 2014 - BusinessWire - BZX
Merck Announces Appointment of Dr. Julie Gerberding as Executive Vice President for Strategic Communications, Global Public Policy and Population Health 9:30 a.m. Dec. 10, 2014 - BusinessWire - BZX
International Breast Cancer Study Group, Breast International Group and Merck Announce Opening of International PANACEA Study of Patients with HER2+ Breast Cancer 8:45 a.m. Dec. 10, 2014 - BusinessWire - BZX
Data Investigating KEYTRUDA® (pembrolizumab), Merck’s Anti-PD-1 Therapy, in Patients with Advanced Triple-Negative Breast Cancer Presented at 2014 San Antonio Breast Cancer Symposium 8:30 a.m. Dec. 10, 2014 - BusinessWire - BZX
